Iron Dextran Administration Guidelines
Initial Test Dose Protocol
- The American Journal of Kidney Diseases recommends administering a one-time test dose of 25 mg IV in adults before initiating iron dextran therapy, with pediatric dosing of 10 mg for patients <10 kg and 15 mg for patients 10-20 kg 1, 2, 3
- The test dose should be observed for at least 60 minutes before proceeding with therapeutic dosing, and if no immediate allergic reaction occurs, subsequent routine doses can be given without repeating the test dose 1, 2, 3
Critical Safety Considerations
- The American Journal of Kidney Diseases notes that most severe anaphylactic reactions to iron dextran occur in patients who previously tolerated both test doses and multiple therapeutic doses, and the test dose does not predict or prevent severe reactions to subsequent doses 1, 2
- Severe reactions requiring resuscitative medications are a risk, although the exact percentage is not specified in the provided citations 1
Mandatory Safety Measures for Every Administration
- The American Journal of Kidney Diseases recommends that personnel trained in emergency treatment be immediately available, resuscitation equipment and medications (epinephrine, diphenhydramine, corticosteroids) be at bedside, and patients be observed for at least 15-60 minutes after administration 1
- The maximum rate of undiluted iron dextran administration should not exceed 50 mg per minute 1